food and drug administration

Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…

Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused…

WASHINGTON (AP) — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido,…

Thousands of bottles of a commonly used prescription drug to treat hypertension has been recalled for possible contamination…

The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…

Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…

MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…

FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…

The use of injectable peptides for a range of perceived health benefits is surging, fueled by aggressive marketing…

Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…

Removing the most dire warning from hormonal therapies to treat menopause is likely the right call, women’s health…

“Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” Today, the FDA…

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)